[1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine

C12H16ClN5 — CID 105253214

IUPAC[1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine
SMILESCCn1ccnc1CC(NN)c1ccc(Cl)nc1
InChIInChI=1S/C12H16ClN5/c1-2-18-6-5-15-12(18)7-10(17-14)9-3-4-11(13)16-8-9/h3-6,8,10,17H,2,7,14H2,1H3
InChIKeyKAUKVOMYKIIJNK-UHFFFAOYSA-N
MW265.75 g/mol
LogP1.70
Rot. Bonds5

About [1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine

[1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine (PubChem CID 105253214) has the molecular formula C12H16ClN5 and a molecular weight of 265.75 g/mol. Its IUPAC name is [1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine.

Molecular Properties

Compound Name[1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine
PubChem CID105253214
Molecular FormulaC12H16ClN5
Molecular Weight265.75 g/mol
Exact Mass265.11
IUPAC Name[1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine
SMILESCCn1ccnc1CC(NN)c1ccc(Cl)nc1
InChIInChI=1S/C12H16ClN5/c1-2-18-6-5-15-12(18)7-10(17-14)9-3-4-11(13)16-8-9/h3-6,8,10,17H,2,7,14H2,1H3
InChIKeyKAUKVOMYKIIJNK-UHFFFAOYSA-N
XLogP1.70
TPSA68.76 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds5
Heavy Atoms18
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500265.75
LogP ≤ 51.70
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Computed Properties (RDKit)

Structural Alerts{'alert_name': '2-halo_pyridine', 'substructure': 'N/A'}, {'alert_name': 'hydrazine', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze [1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

[2-(1-ethylimidazol-2-yl)-1-(4-fluorophenyl)ethyl]hydrazine
CID 105192874
[2-(1-ethylimidazol-2-yl)-1-(4-methylsulfonylphenyl)ethyl]hydrazine
CID 105321777
[2-(1-ethylimidazol-2-yl)-1-(3-fluoro-4-methoxyphenyl)ethyl]hydrazine
CID 105321910
[1-(2-chlorofuran-3-yl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine
CID 106694577
[1-(3-chloro-2-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine
CID 103445832
[2-(1-ethylimidazol-2-yl)-1-(5-fluoro-2-pyridinyl)ethyl]hydrazine
CID 105248555
[1-(4-iodophenyl)-2-(1-propylimidazol-2-yl)ethyl]hydrazine
CID 105323447
[1-(5-bromofuran-2-yl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine
CID 105321933
2-(1-ethylimidazol-2-yl)-1-(6-methyl-3-pyridinyl)ethanol
CID 104823019
[1-(2-ethoxyphenyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine
CID 105260835
[2-(1-ethylimidazol-2-yl)-1-naphthalen-1-ylethyl]hydrazine
CID 105213300
1-(4-bromo-3-chlorophenyl)-2-(1-ethylimidazol-2-yl)-N-methylethanamine
CID 105009485

Frequently Asked Questions

What is the IUPAC name of [1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine?
The IUPAC name of [1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine (CID 105253214) is [1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine.
What is the SMILES notation for [1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine?
The canonical SMILES for [1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine is CCn1ccnc1CC(NN)c1ccc(Cl)nc1.
What is the InChIKey of [1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine?
The InChIKey is KAUKVOMYKIIJNK-UHFFFAOYSA-N. The full InChI is InChI=1S/C12H16ClN5/c1-2-18-6-5-15-12(18)7-10(17-14)9-3-4-11(13)16-8-9/h3-6,8,10,17H,2,7,14H2,1H3.
What are the key properties of [1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine?
[1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine has a molecular weight of 265.75 g/mol, XLogP of 1.70, 5 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for [1-(6-chloro-3-pyridinyl)-2-(1-ethylimidazol-2-yl)ethyl]hydrazine is sourced from PubChem (CID 105253214), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).